GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

ACRO Biomedical Co 6748.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

173.00

+8.13%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 38.3m

FY2018FY2025

Net income

−TWD 82.7m

FY2018FY2025

Free cash flow

−TWD 63.0m

FY2018FY2025

Shareholders' equity

TWD 1.10bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018
RevenueTWD 38.3mTWD 44.2mTWD 51.1mTWD 27.6mTWD 21.8mTWD 18.0mTWD 17.2m
Research and developmentTWD 30.8mTWD 25.7mTWD 28.6mTWD 27.8mTWD 26.0mTWD 31.7mTWD 31.6m
Operating income−TWD 92.9m−TWD 66.5m−TWD 48.7m−TWD 62.8m−TWD 53.6m−TWD 56.0m−TWD 45.2m
Net income−TWD 82.7m−TWD 62.1m−TWD 41.4m−TWD 60.9m−TWD 50.8m−TWD 50.0m−TWD 37.2m
Diluted earnings per share-1.35-1.01-0.71-1.18-0.83-0.82-0.98

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018
Total assetsTWD 1.13bnTWD 655.3mTWD 716.7mTWD 398.5mTWD 151.3mTWD 203.4mTWD 179.0m
Cash and short-term investments—TWD 498.9mTWD 579.2mTWD 316.9mTWD 63.0mTWD 116.8mTWD 102.6m
Total liabilitiesTWD 28.1mTWD 29.1mTWD 30.7mTWD 19.9mTWD 21.3mTWD 25.0mTWD 7.3m
Debt—TWD 15.8mTWD 21.7mTWD 11.8mTWD 13.4mTWD 16.8m—
Shareholders' equityTWD 1.10bnTWD 626.3mTWD 686.1mTWD 378.6mTWD 130.0mTWD 178.4mTWD 171.7m
Shares outstanding61m61m58m51m61m61m38m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018
Cash from operations−TWD 49.0m−TWD 43.4m−TWD 48.3m−TWD 45.2m−TWD 47.8m−TWD 31.3m−TWD 41.7m
Capital spending−TWD 14.0m−TWD 30.6m−TWD 22.5m−TWD 4.4m−TWD 3.3m−TWD 3.8m−TWD 1.5m
Free cash flow−TWD 63.0m−TWD 74.0m−TWD 70.7m−TWD 49.6m−TWD 51.1m−TWD 35.2m−TWD 43.2m

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Jun 2023
RevenueTWD 6.7mTWD 6.7mTWD 23.2mTWD 11.6mTWD 21.0mTWD 10.5mTWD 35.3mTWD 15.8m
Operating income−TWD 22.6m−TWD 22.6m−TWD 35.2m−TWD 17.6m−TWD 29.5m−TWD 14.7m−TWD 16.0m−TWD 32.7m
Net income−TWD 22.0m−TWD 22.0m−TWD 35.7m−TWD 17.9m−TWD 26.4m−TWD 13.2m−TWD 9.9m−TWD 31.5m
Diluted earnings per share-0.36-0.36-0.58-0.29-0.43-0.22-0.17-0.54
Cash from operations−TWD 30.0m−TWD 15.0m−TWD 19.0m−TWD 9.0m−TWD 23.0m−TWD 11.0m−TWD 22.0m−TWD 24.0m
Capital spending−TWD 4.0m−TWD 4.0m−TWD 10.0m−TWD 5.0m−TWD 20.0m−TWD 10.0m−TWD 12.0m−TWD 8.0m
Free cash flow−TWD 34.0m−TWD 19.0m−TWD 29.0m−TWD 14.0m−TWD 43.0m−TWD 21.0m−TWD 34.0m−TWD 32.0m
Total assetsTWD 607.5mTWD 607.5mTWD 655.3mTWD 655.3mTWD 687.8mTWD 687.8mTWD 716.7mTWD 377.8m
Cash and short-term investmentsTWD 453.3mTWD 453.3mTWD 498.9mTWD 498.9mTWD 531.9mTWD 531.9mTWD 579.2mTWD 280.6m
DebtTWD 3.8mTWD 3.8mTWD 5.3mTWD 5.3mTWD 10.7mTWD 5.3mTWD 5.8mTWD 5.3m
Shareholders' equityTWD 581.4mTWD 581.4mTWD 626.3mTWD 626.3mTWD 660.5mTWD 660.5mTWD 686.1mTWD 347.1m

Financial ratios

Data as of 17 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-215.5%-139.7%-80.6%-220.0%-232.2%-276.8%—
Net margin-216.1%-140.4%-81.1%-220.3%-232.6%-277.4%—
Return on equity-7.5%-9.9%-6.0%-16.1%-39.1%-28.0%—
Return on assets-7.3%-9.5%-5.8%-15.3%-33.6%-24.6%—
Free cash flow yield-0.3%-0.1%-0.2%-0.4%———
Revenue growth-13.5%-13.4%84.8%26.6%21.0%——
Earnings growth33.1%49.9%-32.0%19.9%1.5%——
Current ratio51.12x28.68x41.04x27.68x9.01x10.98x—
Debt to equity—0.02x0.01x0.01x0.03x0.03x0.02x
Equity ratio97.5%95.6%95.7%95.0%85.9%87.7%—
Interest coverage-368.00x-216.03x-157.08x-607.84x-575.99x-484.61x—
R&D as a share of sales80.6%58.1%56.1%100.8%119.3%175.8%—
Buybacks as a share of market value0.0%-5.5%-12.7%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.5%16.2%—
Operating income14.0%10.7%—
Net income10.7%10.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-193.2%-168.0%-189.2%—
Net margin-175.5%-153.3%-173.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-48.3-25.0-55.1-16.9-31.9
Price to sales104.335.144.737.374.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.